PubMed · 1697379
Angiotensin II inhibits cortical cholinergic function: implications for cognition.
Abstract
In the present studies we have shown that angiotensin II (AT II), in a concentration-dependent manner in rat tissue (10(-9)-10(-5) M) or at a single concentration in human tissue (10(-6) M), can inhibit potassium-stimulated release of [3H]acetylcholine ( [3H]Ach) from slices of rat entorhinal cortex and human temporal cortex preloaded with [3H]choline for the biochemical analyses. The inhibitory effects of AT II (10(-6) M) were antagonised by the specific AT II receptor antagonist [1-sarcosine, 8-threonine]AT II in a concentration-dependent manner in rat tissue (10(-11)-10(-8) M) and at the single concentration employed in the human studies (10(-7) M). Also demonstrated were other components of the angiotensin system in the human temporal cortex; ACE activity was present (1.03 nmol min-1 mg-1 protein), as were AT II recognition sites (Bmax = 8.6 fmol mg-1 protein). It is hypothesised that the potential cognitive enhancing properties of ACE inhibitors may reflect their action to prevent the formation of AT II and so remove an inhibitory modulator of cholinergic function.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
J M Barnes, N M Barnes, B Costall, Z P Horovitz, J W Ironside, R J Naylor, T J Williams. 1990. Angiotensin II inhibits cortical cholinergic function: implications for cognition.. https://doi.org/10.1097/00005344-199008000-00009
Cite the original work for its findings. Save a collection to share your selection of sources.